Stock Price
2.27
Daily Change
-0.03 -1.30%
Monthly
-4.62%
Yearly
-29.50%
Q2 Forecast
2.20

Bioline Rx reported $831K in Selling and Administration Expenses for its fiscal quarter ending in September of 2025.





Selling And Administration Expenses Change Date
Arca Biopharma USD 2.23M 1.08M Dec/2025
Bio Path USD 199K 300K Sep/2025
Bioline Rx USD 831K 622K Sep/2025
Capricor Therapeutics USD 1.92M 446.47K Dec/2025